You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Sotrovimab

Showing 1 - 21 of 21
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Covid19 Trial in United States (sotrovimab)

Recruiting
  • Covid19
  • sotrovimab
  • Riverside, California
  • +9 more
Nov 2, 2022

Covid19 Trial in United States (Sotrovimab)

No longer available
  • Covid19
  • Sotrovimab
  • Palo Alto, California
  • +3 more
Nov 4, 2022

COVID-19 Infection, Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Seattle (Questionnaire Administration,

Suspended
  • COVID-19 Infection
  • +2 more
  • Questionnaire Administration
  • Sotrovimab
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 24, 2023

Covid19 Trial in Anaheim, Glendale (sotrovimab, Placebo to Biologic)

Completed
  • Covid19
  • sotrovimab
  • Placebo to Biologic
  • Anaheim, California
  • +1 more
May 2, 2022

Immune Response to COVID-19 Infection in Real-life in UAE and

Recruiting
  • COVID-19
  • Sotrovimab
  • Manama, Bahrain
    The National Taskforce for combating COVID-19, Royal Medical Ser
May 30, 2022

COVID-19 Trial in United Kingdom (Sotrovimab)

Recruiting
  • COVID-19
  • Sotrovimab
  • Cardiff, United Kingdom
  • +3 more
Jul 25, 2022

COVID-19 Trial in Worldwide (Sotrovimab)

Recruiting
  • COVID-19
  • Sotrovimab
  • Cullman, Alabama
  • +17 more
Nov 4, 2022

SARS CoV 2 Infection Trial in Boston (Sotrovimab)

Recruiting
  • SARS CoV 2 Infection
  • Sotrovimab
  • Boston, Massachusetts
  • +2 more
Jan 26, 2022

Monoclonal Antibodies (Sotrovimab )

Recruiting
  • COVID-19 Respiratory Infection
    • Dubai, United Arab Emirates
      Emirats Health Service
    Dec 13, 2021

    COVID-19 International Drug Pregnancy Registry

    Recruiting
    • Covid19
    • Antiviral Agents
    • Monoclonal antibody
    • Los Angeles, California
      Pregistry
    Jul 20, 2022

    Covid19 Trial in Pittsburgh (Lilly Bamlanivimab, Regeneron Casirivimab + Imdevimab, Lilly Bamlanivimab + Etesevimab)

    Completed
    • Covid19
    • Lilly Bamlanivimab
    • +4 more
    • Pittsburgh, Pennsylvania
      UPMC
    Jun 16, 2022

    Covid19 Trial in Worldwide (Sotrovimab (Gen1), Sotrovimab (Gen2))

    Active, not recruiting
    • Covid19
    • Sotrovimab (Gen1)
    • Sotrovimab (Gen2)
    • Anniston, Alabama
    • +30 more
    Feb 4, 2022

    Covid19, Nosocomial Infection, SARS-CoV2 Infection Trial in Canada (Anti-SARS-CoV-2 mAb)

    Suspended
    • Covid19
    • +2 more
    • Anti-SARS-CoV-2 mAb
    • Calgary, Alberta, Canada
    • +3 more
    Nov 30, 2021

    COVID-19 Trial in Italy (Sotrovimab, Tixagevimab Cilgavimab, Nirmatrelvir Ritonavir)

    Recruiting
    • COVID-19
    • Sotrovimab
    • +2 more
    • Bologna, Italy
    • +18 more
    Nov 22, 2022

    TURN-COVID Biobank: The Dutch Cohort Study for Evaluation of Use

    Recruiting
    • COVID-19
    • casirivimab with imdevimab
    • +2 more
    • Amsterdam, Noord Holland, Netherlands
    • +3 more
    Jan 13, 2022

    Covid19 Trial in United Kingdom (Niclosamide, Placebo, Ciclesonide)

    Recruiting
    • Covid19
    • Cambridge, Cambridgeshire, United Kingdom
    • +34 more
    Feb 20, 2022

    Covid19 Trial in Worldwide (VIR-7831, Placebo)

    Completed
    Has Results
    • Covid19
    • VIR-7831 (sotrovimab)
    • Placebo
    • Anniston, Alabama
    • +90 more
    Oct 12, 2022

    COVID-19 Trial in France, Germany, United Kingdom (COVID-19 convalescent and vaccinated plasma, Current standard of care)

    Recruiting
    • COVID-19
    • COVID-19 convalescent and vaccinated plasma
    • Current standard of care
    • Besançon, France
    • +10 more
    May 3, 2022

    A Real-World Study of Anti-SARS-CoV-2 Monoclonal Antibodies

    Recruiting
    • Immunocompromised Patients
    • Data collection
    • Paris, Ile De France, France
      Assistance Publique - Hôpitaux de Paris (AP-HP) - Cochin Hospita
    Jul 5, 2022

    COVID-19 Trial in Worldwide (BRII-196, BRII-198, Placebo)

    Completed
    • COVID-19
    • BRII-196
    • +3 more
    • Tucson, Arizona
    • +106 more
    Mar 24, 2023

    COVID-19, SARS-CoV-2 Trial in Worldwide (AZD5156, Placebo, AZD7442 (EVUSHELD™))

    Recruiting
    • COVID-19, SARS-CoV-2
    • AZD5156
    • +2 more
    • Buenos Aires, Argentina
    • +20 more
    Jan 12, 2023